CF
ContraFect Corp.
CFRXQ · OTC
$0.00 +0.00% (+$0.00)
Market Cap $107.0
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
0/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 4,817.02%
ROA 315.07%
Asset turnover 0.00x
Debt
78 /100
Low Current ratio 0.85x
Net debt/EBITDA 0.09x
Debt/Equity N/A
Stability
19 /100
Unstable Beta -9.57x
EPS volatility 128.78%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na CFRXQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Roger J. Pomerantz
Employees
23
Headquarters
Yonkers
Nadcházející události
16 LIS
Earnings
Upcoming earnings report